The influence of UGT polymorphisms as biomarkers in solid organ transplantation - Wikidata - awgldk - TriplyDB

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

http://www.wikidata.org/entity/Q27009825

about

The correlation between the expression of genes involved in drug metabolism and the blood level of tacrolimus in liver transplant receipts Species differences in sinusoidal and canalicular efflux transport of mycophenolic acid 7-O-glucuronide in sandwich-cultured hepatocytes.Role of pharmacogenomics in dialysis and transplantation Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation.Higher plasma bilirubin predicts veno-occlusive disease in early childhood undergoing hematopoietic stem cell transplantation with cyclosporine.Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation.Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.

P2860

Q33793971-FC107B9A-1E5C-4B5E-BADA-B69626DED190 Q34286869-CACDD9EE-EC8B-4A5A-99A7-D3121E2E4111 Q34454797-583FC97B-8816-4872-8378-9B289856B95A Q36183911-5412DFCA-50FD-445C-9377-C232BA0D21C2 Q37035212-3C0D1271-BE3A-4801-89FF-077481ECCE44 Q37297477-0D687BB3-395F-458F-981D-25AD2C33DBCA Q38208983-D1B184CF-5D87-4EF0-A9C0-97C2A3934CFF Q38896041-1E3F6845-6665-43C7-941C-22D14BC6A8C4 Q47678205-E6390B0B-2581-445F-99D0-AE27D23F8A9D Q48252498-67466553-CBD1-4464-A7BA-173FF8EFCA94

P2860

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

http://www.wikidata.org/entity/Q27009825

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@ast

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@en

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@nl

type

label

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@ast

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@en

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@nl

prefLabel

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@ast

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@en

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@nl

P1433

Q27009825-1E930714-1003-4083-90E1-8CF1AC71FB39

P1476

Q27009825-86572CDF-E0B7-4C64-88C7-6AEE8B87057B

P2093

Q27009825-0EB6E67D-93AA-452B-A6A2-0FE5939AFF7B

Q27009825-F02691AD-9C56-485B-9700-EB12562B05C2

Q27009825-F10BEF86-DB79-4C2D-9B4B-EE691E0D2583

P2860

Q27009825-02C2EB19-6CBA-41BD-9212-35A3E6B24347

Q27009825-03893DD0-F16A-45AF-82C2-ED5163D987CD

Q27009825-0D148B19-4975-42B8-A66D-38A914E83F2B

Q27009825-19CF00C0-9706-439C-B242-ED1B3AE729F9

Q27009825-21C2BCC9-D0B8-47DD-99A5-6F041356374C

Q27009825-2CAE24B5-B683-4ABF-A32B-0E2D6FFF6B5D

Q27009825-358D7462-B321-449D-AB7C-DF5868B43DA6

Q27009825-3B33C1D9-FF1D-435B-8893-6E498B66E0F5

Q27009825-40660823-EA3A-4C56-8ECA-E4AEB88B346A

Q27009825-46203EFD-8406-4CB1-A825-AAFFC5860522

P304

Q27009825-4A857DA2-3A85-4D2B-8C46-157DB46AB4BD

P31

Q27009825-7246953C-1519-4D56-8D3E-CAEE3178FA4C

P3181

Q27009825-AA342C47-B589-4B6E-B27B-E88D80BBDA4F

P356

Q27009825-3B08DAD1-88B4-4327-921D-F4F2152BC181

P407

Q27009825-A970BFC1-8AD9-4D76-B8B1-C277527373FE

P433

Q27009825-655F32BE-49A0-4F77-B5A9-AD7DC063F489

P478

Q27009825-31FF097F-70DE-4A9A-A8E0-54660DDCCF2B

P577

Q27009825-F3A745C4-7312-45F4-94B8-C7CC2B79E60A

P698

Q27009825-CC70D19A-00D1-47AA-B472-D4C3A4F6E4C0

P921

Q27009825-2C559F03-0FB4-4EFF-9F2E-D6367BF64A74

Q27009825-E365FBB3-9775-4CBE-81DB-5D1CE0D81754

P932

Q27009825-5C5F80B3-F172-4A60-98F6-14E94DF42A7B

P3181

P356

J.CCA.2012.01.031

P1433

Clinica Chimica Acta

P1476

The influence of UGT polymorphisms as biomarkers in solid organ transplantation

@en

P2093

Andrea Yuen

http://www.w3.org/2001/XMLSchema#string

Federico Innocenti

http://www.w3.org/2001/XMLSchema#string

Robert Dupuis

http://www.w3.org/2001/XMLSchema#string

P2860

Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele

Genetic polymorphisms of MRP2 and UGT2B7 and gastrointestinal symptoms in renal transplant recipients taking mycophenolic acid

Excerpts from the US Renal Data System 2009 Annual Data Report.

The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation.

Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.

UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients.

UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.

The prevalence of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T and its influence on mycophenolic acid pharmacokinetics in stable renal transplant patients.

Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.

Acyl glucuronide drug metabolites: toxicological and analytical implications.

P304

1318-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4182269

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CCA.2012.01.031

http://www.w3.org/2001/XMLSchema#string

P407

P433

17-18

http://www.w3.org/2001/XMLSchema#string

P478

413

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22327003

http://www.w3.org/2001/XMLSchema#string

P921

organ transplantation

P932

3795433

http://www.w3.org/2001/XMLSchema#string